Literature DB >> 25486321

Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.

Wei Xu1, Deying Chen, Nan Wang, Ting Zhang, Ruokun Zhou, Tao Huan, Yingfeng Lu, Xiaoling Su, Qing Xie, Liang Li, Lanjuan Li.   

Abstract

Human fecal samples contain endogenous human metabolites, gut microbiota metabolites, and other compounds. Profiling the fecal metabolome can produce metabolic information that may be used not only for disease biomarker discovery, but also for providing an insight about the relationship of the gut microbiome and human health. In this work, we report a chemical isotope labeling liquid chromatography-mass spectrometry (LC-MS) method for comprehensive and quantitative analysis of the amine- and phenol-containing metabolites in fecal samples. Differential (13)C2/(12)C2-dansyl labeling of the amines and phenols was used to improve LC separation efficiency and MS detection sensitivity. Water, methanol, and acetonitrile were examined as an extraction solvent, and a sequential water-acetonitrile extraction method was found to be optimal. A step-gradient LC-UV setup and a fast LC-MS method were evaluated for measuring the total concentration of dansyl labeled metabolites that could be used for normalizing the sample amounts of individual samples for quantitative metabolomics. Knowing the total concentration was also useful for optimizing the sample injection amount into LC-MS to maximize the number of metabolites detectable while avoiding sample overloading. For the first time, dansylation isotope labeling LC-MS was performed in a simple time-of-flight mass spectrometer, instead of high-end equipment, demonstrating the feasibility of using a low-cost instrument for chemical isotope labeling metabolomics. The developed method was applied for profiling the amine/phenol submetabolome of fecal samples collected from three families. An average of 1785 peak pairs or putative metabolites were found from a 30 min LC-MS run. From 243 LC-MS runs of all the fecal samples, a total of 6200 peak pairs were detected. Among them, 67 could be positively identified based on the mass and retention time match to a dansyl standard library, while 581 and 3197 peak pairs could be putatively identified based on mass match using MyCompoundID against a Human Metabolome Database and an Evidence-based Metabolome Library, respectively. This represents the most comprehensive profile of the amine/phenol submetabolome ever detected in human fecal samples. The quantitative metabolome profiles of individual samples were shown to be useful to separate different groups of samples, illustrating the possibility of using this method for fecal metabolomics studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25486321     DOI: 10.1021/ac503619q

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  15 in total

1.  Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.

Authors:  Zhi-Lan Zhou; Xue-Bing Jia; Meng-Fei Sun; Ying-Li Zhu; Chen-Meng Qiao; Bo-Ping Zhang; Li-Ping Zhao; Qin Yang; Chun Cui; Xue Chen; Yan-Qin Shen
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

2.  Chemical Isotope Labeling LC-MS for Metabolomics.

Authors:  Shuang Zhao; Liang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Lactobacillus rhamnosus GG modifies the metabolome of pathobionts in gnotobiotic mice.

Authors:  Jinhee Kim; Iyshwarya Balasubramanian; Sheila Bandyopadhyay; Ian Nadler; Rajbir Singh; Danielle Harlan; Amanda Bumber; Yuling He; Lee J Kerkhof; Nan Gao; Xiaoyang Su; Ronaldo P Ferraris
Journal:  BMC Microbiol       Date:  2021-06-03       Impact factor: 3.605

4.  Method for absolute quantification of short chain fatty acids via reverse phase chromatography mass spectrometry.

Authors:  Dominique G Bihan; Thomas Rydzak; Madeleine Wyss; Keir Pittman; Kathy D McCoy; Ian A Lewis
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.240

5.  Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.

Authors:  Rashmi Sinha; Jiyoung Ahn; Joshua N Sampson; Jianxin Shi; Guoqin Yu; Xiaoqin Xiong; Richard B Hayes; James J Goedert
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

Review 6.  Current and Future Perspectives on the Structural Identification of Small Molecules in Biological Systems.

Authors:  Daniel A Dias; Oliver A H Jones; David J Beale; Berin A Boughton; Devin Benheim; Konstantinos A Kouremenos; Jean-Luc Wolfender; David S Wishart
Journal:  Metabolites       Date:  2016-12-15

Review 7.  Noninvasive metabolic profiling for painless diagnosis of human diseases and disorders.

Authors:  Mainak Mal
Journal:  Future Sci OA       Date:  2016-06-10

Review 8.  Exploring the human microbiome from multiple perspectives: factors altering its composition and function.

Authors:  David Rojo; Celia Méndez-García; Beata Anna Raczkowska; Rafael Bargiela; Andrés Moya; Manuel Ferrer; Coral Barbas
Journal:  FEMS Microbiol Rev       Date:  2017-07-01       Impact factor: 16.408

9.  Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model.

Authors:  Deying Chen; Xiaoling Su; Nan Wang; Yunong Li; Hua Yin; Liang Li; Lanjuan Li
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

10.  Identification of weak and gender specific effects in a short 3 weeks intervention study using barley and oat mixed linkage β-glucan dietary supplements: a human fecal metabolome study by GC-MS.

Authors:  Alessia Trimigno; Bekzod Khakimov; Josue Leonardo Castro Mejia; Mette Skau Mikkelsen; Mette Kristensen; Birthe Møller Jespersen; Søren Balling Engelsen
Journal:  Metabolomics       Date:  2017-08-18       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.